首页> 外文期刊>Digestion >Clinical features of gastrointestinal follicular lymphoma: comparison with nodal follicular lymphoma and gastrointestinal MALT lymphoma.
【24h】

Clinical features of gastrointestinal follicular lymphoma: comparison with nodal follicular lymphoma and gastrointestinal MALT lymphoma.

机译:胃肠道滤泡性淋巴瘤的临床特征:与淋巴结滤泡性淋巴瘤和胃肠道MALT淋巴瘤的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

We retrospectively compared the clinicopathological features of primary intestinal follicular lymphomas (FL-GIs), nodal follicular lymphomas (FL-LNs) and gastrointestinal MALT lymphomas (MALT-GIs), and investigated the distribution and the endoscopic appearances of FL-GI to evaluate the effectiveness of treatment modality. The subjects were 28 FL-GI patients, 135 FL-LN patients and 70 MALT-GI patients. In FL-LNs the clinical stage III-IV was 83%, while in FL-GIs clinical stage I-II was 68%. In MALT-GIs clinical stage I-II was 87%. The overall survival was significantly better in MALT-GI patients than in FL-LN patients. All FL-GI patients were alive at the time of evaluation. Regarding the histological grade (WHO), grade 1 was 81% in FL-GI, whereas in FL-LN grade 2 was 28% and grade 3 was 11%. The Follicular Lymphoma International Prognostic Index was low in 61% of FL-GIs, while in FL-LNs it was equally distributed to low, intermediate and high, suggesting that the prognosis is better in FL-GIs than in FL-LNs. The clinicopathological studies revealed the FL-GI has intermediate characteristics between FL-LN and MALT-GI. We recommend a 'watch-and-wait' policy or chemotherapy with rituximab for the therapy of FL-GIs because the lesions are often located in broader areas from the lower duodenum to the small intestine.
机译:我们回顾性比较了原发性肠道滤泡性淋巴瘤(FL-GIs),淋巴结滤泡性淋巴瘤(FL-LNs)和胃肠道MALT淋巴瘤(MALT-GIs)的临床病理特征,并调查了FL-GI的分布和内窥镜表现以评估治疗方式的有效性。受试者为28名FL-GI患者,135名FL-LN患者和70名MALT-GI患者。在FL-LN中,临床III-IV期为83%,而在FL-GIs中,临床I-II期为68%。在MALT-GIs中,I-II期为87%。 MALT-GI患者的总生存期明显优于FL-LN患者。在评估时,所有FL-GI患者都还活着。就组织学等级(WHO)而言,FL-GI的等级为1%,为81%,而FL-LN的等级为2%,为28%,3级为11%。滤泡性淋巴瘤国际预后指数在FL-GIs中为61%较低,而在FL-LNs中,它​​均匀分布在低,中和高水平,提示FL-GIs的预后要好于FL-LN。临床病理研究表明,FL-GI在FL-LN和MALT-GI之间具有中间特征。我们建议采取“观察和等待”政策或利妥昔单抗化疗治疗FL-GI,因为病变通常位于从十二指肠下端到小肠的较宽区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号